Neurolens, Inc. announced that it has raised $45 million in venture debt from new investor, Trinity Capital Inc. on December 5, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.98 USD | +0.07% | +1.01% | +3.10% |
07/05 | Trinity Capital Inc. Announces Director Appointments | CI |
02/05 | B. Riley Adjusts Trinity Capital's Price Target to $16 From $16.50, Keeps Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.10% | 74Cr | |
-1.09% | 12TCr | |
+14.62% | 6.73TCr | |
+18.97% | 6.31TCr | |
+12.10% | 4.36TCr | |
+14.61% | 4.32TCr | |
+21.85% | 3.58TCr | |
+6.19% | 2.55TCr | |
-1.16% | 2.31TCr | |
+7.02% | 1.97TCr |
- Stock Market
- Equities
- TRIN Stock
- News Trinity Capital Inc.
- Neurolens, Inc. announced that it has received $45 million in funding from Trinity Capital Inc.